Related Experiment Video

Updated: Mar 7, 2026

Intracerebroventricular Treatment with Resiniferatoxin and Pain Tests in Mice
06:04

Intracerebroventricular Treatment with Resiniferatoxin and Pain Tests in Mice

Published on: September 2, 2020

9.0K

Vanillin Protects Dopaminergic Neurons against Inflammation-Mediated Cell Death by Inhibiting ERK1/2, P38 and the

Xuan Yan1, Dian-Feng Liu2, Xiang-Yang Zhang3

  • 1College of Animal Science and Veterinary Medicine, Jilin University, Changchun 130062, China. yanxuan1992@outlook.com.

International Journal of Molecular Sciences
|February 18, 2017
PubMed

Insights

Vanillin protects against Parkinson's disease by reducing neuroinflammation and protecting dopaminergic neurons. It inhibits microglial activation and inflammatory signaling pathways, offering a potential therapeutic strategy for Parkinson's disease.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Neuroinflammation

Background:

  • Neuroinflammation, driven by activated microglia releasing inflammatory mediators, is crucial in Parkinson's disease (PD) pathogenesis.
  • Inhibiting microglial activation presents a potential therapeutic avenue for PD.
  • Vanillin's neuroprotective effects on dopaminergic neurons are known, but the underlying mechanisms require further elucidation.

Purpose of the Study:

  • To investigate the protective mechanisms of vanillin in a lipopolysaccharide (LPS)-induced Parkinson's disease (PD) model.
  • To analyze vanillin's effects on motor function, dopaminergic neuron degeneration, and microglial activation in vivo.
  • To explore vanillin's impact on inflammatory responses and signaling pathways in vitro.

Main Methods:

  • Established rat models of PD via unilateral LPS injection into the substantia nigra (SN).
  • Administered vanillin to rats and assessed motor function, dopaminergic neuron survival, and microglial activation.
  • Treated murine microglial BV-2 cells with vanillin before LPS exposure to analyze inflammatory markers and signaling pathways (ERK1/2, p38, NF-κB).

Main Results:

  • Vanillin significantly improved motor dysfunction in LPS-induced PD rat models.
  • Vanillin suppressed dopaminergic neuron degeneration and inhibited microglial over-activation in vivo.
  • In vitro, vanillin reduced LPS-induced expression of iNOS, COX-2, IL-1β, and IL-6 by modulating ERK1/2, p38, and NF-κB signaling.

Conclusions:

  • Vanillin demonstrates significant neuroprotective effects in a Parkinson's disease model.
  • Vanillin mitigates neuroinflammation by inhibiting microglial activation and pro-inflammatory mediator production.
  • The findings suggest vanillin's potential as a therapeutic agent for Parkinson's disease by targeting neuroinflammatory pathways.
Keywords:
MAPKNF-κBParkinson’s diseaseinflammationmicrogliavanillin

More Related Videos

Primary Culture of Mouse Dopaminergic Neurons11:58

Primary Culture of Mouse Dopaminergic Neurons

Published on: September 8, 2014

39.6K

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.2K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.4K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.0K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.1K